RecruitingNot ApplicableNCT07485075
Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial
SBI 2024-2026 STENO FOOD CONCEPT
Sponsor
Steno Diabetes Center Copenhagen
Enrollment
104 participants
Start Date
Mar 20, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Eligibility
Min Age: 18 YearsMax Age: 74 Years
Inclusion Criteria6
- Type 2 diabetes (ICD-10 DE11.x)
- Age 18-74 years
- BMI < 35 kg/m²
- eGFR 30-59 ml/min and UACR > 30 mg/g
- Stable medication for ≥3 months
- Ability to read and understand Danish
Exclusion Criteria6
- Type 1 diabetes or other diabetes types
- Current vegan diet
- Active cancer
- Short bowel syndrome or celiac disease
- Use of sodium chloride tablets
- No access to digital platform (intervention group only)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEStenoFood App
Digital patient education program (app-based) with dietary guidance and self-monitoring tools
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07485075
Related Trials
Immune System Related Kidney Disease
NCT000019791 location
Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
NCT071767931 location
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
NCT06963827140 locations
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
NCT070599624 locations
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
NCT074263802 locations